The earnings call reflected a cautiously optimistic outlook with Agilent's strategic initiatives and market recovery showing promise. However, challenges in certain segments and geographies, particularly China, indicate areas needing attention. The strong cash flow, new organizational structure, and product launches are positive indicators for future growth.

Company Guidance

During the Agilent Technologies, Inc. Q4 2024 earnings call, the company projected its fiscal year 2025 guidance, expecting revenue between $6.79 billion and $6.87 billion, translating to reported growth of 4.3% to 5.5%. The guidance includes a slight currency headwind of 0.2%, with BIOVECTRA acquisitions contributing 2-2.2% to growth. Core growth is anticipated at 2.5% to 3.5%. For Q1 2025, revenue is forecasted between $1.65 billion and $1.68 billion, with core growth ranging from a decline of 2% to flat, factoring in a 2% negative impact due to the Lunar New Year timing. Operating margins are projected to expand by 50 to 70 basis points for the year, supported by the Ignite transformation initiative. Non-GAAP EPS is expected to range from $5.54 to $5.61, reflecting a 5% to 6% growth, with cash flow remaining strong at approximately $1.65 billion.

Solid Fourth Quarter Results

Agilent delivered revenue of $1.701 billion in Q4, with a book-to-bill ratio greater than 1, indicating a steady market improvement and share gains in all geographies.

New Market-Focused Organizational Structure

Agilent announced a new market-focused organizational structure to become more customer-centric and accelerate performance, aligning business units to markets.

Infinity III LC Series Launch

Agilent launched the Infinity III LC series, featuring advanced automation and eco-friendly certifications, with positive early customer traction.

BIOVECTRA Acquisition Completed

The acquisition of BIOVECTRA was completed, expanding Agilent's CDMO services into new therapeutic modalities like peptide synthesis.

Strong Cash Flow and Shareholder Returns

Agilent reported $481 million in Q4 operating cash flow, exceeding expectations, and returned over $1.4 billion to shareholders in FY 2024.

Recognition as a Top Workplace

Fortune magazine named Agilent #11 among the world's best workplaces in 2024, highlighting the company's outstanding culture.

---

Agilent (A) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

A Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 25, 2025	2025 (Q1)	1.27 / -	1.29	―	―	―
Nov 25, 2024	2024 (Q4)	1.41 / 1.46	1.38	5.80% (+0.08)
Aug 21, 2024	2024 (Q3)	1.26 / 1.32	1.43	-7.69% (-0.11)
May 29, 2024	2024 (Q2)	1.19 / 1.22	1.27	-3.94% (-0.05)
Feb 27, 2024	2024 (Q1)	1.23 / 1.29	1.37	-5.84% (-0.08)
Nov 20, 2023	2023 (Q4)	1.34 / 1.38	1.53	-9.80% (-0.15)
Aug 15, 2023	2023 (Q3)	1.36 / 1.43	1.34	6.72% (+0.09)
May 23, 2023	2023 (Q2)	1.26 / 1.27	1.13	12.39% (+0.14)
Feb 28, 2023	2023 (Q1)	1.31 / 1.37	1.21	13.22% (+0.16)
Nov 21, 2022	2022 (Q4)	1.39 / 1.53	1.21	26.45% (+0.32)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

A Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 25, 2024	$134.49	$134.37	-0.09%
Aug 21, 2024	$139.77	$140.00	+0.16%
May 29, 2024	$144.98	$130.97	-9.66%
Feb 27, 2024	$131.88	$136.32	+3.37%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---